By Elaine Meyer ( April 30, 2010, 2:28 PM EDT) -- In a ruling in line with recent federal appeals court decisions, a district judge has held that Wyeth Inc. and Schwarz Pharma Inc., makers of brand-name gastric reflux drug Reglan, cannot be held liable for the failure of its generic rivals to include warnings that the product could cause a neurological disorder....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.